Cargando…

ARPNet: Antidepressant Response Prediction Network for Major Depressive Disorder

Treating patients with major depressive disorder is challenging because it takes several months for antidepressants prescribed for the patients to take effect. This limitation may result in increased risks and treatment costs. To address this limitation, an accurate antidepressant response predictio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Buru, Choi, Yonghwa, Jeon, Minji, Lee, Junhyun, Han, Kyu-Man, Kim, Aram, Ham, Byung-Joo, Kang, Jaewoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895829/ https://www.ncbi.nlm.nih.gov/pubmed/31703457 http://dx.doi.org/10.3390/genes10110907

Ejemplares similares

The Indirect Effect of Prefrontal Gray Matter Volume on Suicide Attempts among Individuals with Major Depressive Disorder
por: Kang, June, et al.
Publicado: (2022)

Reduced Sulcal Depth in Central Sulcus of Major Depressive Disorder
por: Shin, Seung-Joon, et al.
Publicado: (2022)

Childhood Sexual Abuse and Cortical Thinning in Adults With Major Depressive Disorder
por: Kim, Jinyi, et al.
Publicado: (2023)

Association of DNA Methylation of the NLRP3 Gene with Changes in Cortical Thickness in Major Depressive Disorder
por: Han, Kyu-Man, et al.
Publicado: (2022)

The Association of White Matter Tracts with Alexithymia among Individuals with Major Depressive Disorder
por: Kang, Youbin, et al.
Publicado: (2022)

Alterations in the Occipital Cortex of Drug-Naïve Adults With Major Depressive Disorder: A Surface-Based Analysis of Surface Area and Cortical Thickness
por: Lee, Jee Soo, et al.
Publicado: (2021)

Local shape volume alterations in subcortical structures of suicide attempters with major depressive disorder
por: Kang, Wooyoung, et al.
Publicado: (2020)

Association Between the C4 Binding Protein Level and White Matter Integrity in Major Depressive Disorder
por: Park, Jihoon, et al.
Publicado: (2022)

The association between substance P and white matter integrity in medication-naive patients with major depressive disorder
por: Won, Eunsoo, et al.
Publicado: (2017)

Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder
por: Kim, Jae-Won, et al.
Publicado: (2013)

A Pilot Study of Biomedical Text Comprehension using an Attention-Based Deep Neural Reader: Design and Experimental Analysis
por: Kim, Seongsoon, et al.
Publicado: (2018)

Should antidepressants be used for major depressive disorder?
por: Jakobsen, Janus Christian, et al.
Publicado: (2020)

CYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression
por: Han, Kyu-Man, et al.
Publicado: (2013)

Association between Glucocorticoid Receptor Methylation and Hippocampal Subfields in Major Depressive Disorder
por: Na, Kyoung-Sae, et al.
Publicado: (2014)

Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder
por: Han, Kyu-Man, et al.
Publicado: (2017)

Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism
por: Won, Eunsoo, et al.
Publicado: (2016)

Effects of a Polymorphism of the Neuronal Amino Acid Transporter SLC6A15 Gene on Structural Integrity of White Matter Tracts in Major Depressive Disorder
por: Choi, Sunyoung, et al.
Publicado: (2016)

Decreased Total Antioxidant Activity in Major Depressive Disorder Patients Non-Responsive to Antidepressant Treatment
por: Baek, Song-Eun, et al.
Publicado: (2016)

Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder
por: Hung, Yi-Yung, et al.
Publicado: (2015)

Cortical Thickness and Surface Area Abnormalities in Bipolar I and II Disorders
por: Woo, Yoonmi, et al.
Publicado: (2021)

Noncontinuous use of antidepressant in adults with major depressive disorders – a retrospective cohort study
por: Yau, Wai-Yin, et al.
Publicado: (2014)

Identifying resting‐state effective connectivity abnormalities in drug‐naïve major depressive disorder diagnosis via graph convolutional networks
por: Jun, Eunji, et al.
Publicado: (2020)

Quantifying the level of difficulty to treat major depressive disorder with antidepressants: Treatment Resistance to Antidepressants Evaluation Scale
por: Liu, Tzu-Yu, et al.
Publicado: (2020)

The Use of Antidepressant Drugs and the Lifetime Prevalence of Major Depressive Disorders in Italy
por: Carta, Mauro Giovanni, et al.
Publicado: (2010)

Antidepressant medication treatment patterns in Asian patients with major depressive disorder
por: Novick, Diego, et al.
Publicado: (2015)

How Inflammation Affects the Brain in Depression: A Review of Functional and Structural MRI Studies
por: Han, Kyu-Man, et al.
Publicado: (2021)

Impact of Early-Life Stress and Resilience on Patients with Major Depressive Disorder
por: Seok, Jeong-Ho, et al.
Publicado: (2012)

BERN2: an advanced neural biomedical named entity recognition and normalization tool
por: Sung, Mujeen, et al.
Publicado: (2022)

Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
por: Kato, Masaki, et al.
Publicado: (2020)

Association Between Antidepressant Efficacy and Interactions of Three Core Depression-Related Brain Networks in Major Depressive Disorder
por: Wang, Qiang, et al.
Publicado: (2022)

Antidepressant Treatment-Induced State-Dependent Reconfiguration of Emotion Regulation Networks in Major Depressive Disorder
por: Zhao, Lei, et al.
Publicado: (2022)

Suicidal Risks in Reports of Long-Term Controlled Trials of Antidepressants for Major Depressive Disorder II
por: Baldessarini, Ross J., et al.
Publicado: (2016)

Predictors of Cognitive Improvement during 12 Weeks of Antidepressant Treatment in Patients with Major Depressive Disorder
por: Lee, Jeong-Ok, et al.
Publicado: (2018)

New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
por: Katona, Cornelius L, et al.
Publicado: (2014)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder
por: Jung, Woo-Young, et al.
Publicado: (2016)

Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response
por: Myung, Woojae, et al.
Publicado: (2016)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
por: Fontana, Andrea, et al.
Publicado: (2020)

Transcranial Magnetic Stimulation Markers of Antidepressant Treatment in Adolescents With Major Depressive Disorder
por: Doruk Camsari, Deniz, et al.
Publicado: (2019)

Increased Cortical Thickness in Patients With Major Depressive Disorder Following Antidepressant Treatment
por: Nemati, Samaneh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f54bp2dn5saplflboh4dmb99p6